At the interface between ER and mitochondria: inhibition of SOAT1 as a new treatment strategy against adrenocortical carcinoma
Hauptforscher:innen

Prof. Dr. med. Martin Fassnacht
fassnacht_m[at]ukw.de
Department of Internal Medicine I, Endocrinology & Diabetology, Universitätsklinikum Würzburg
PD Dr. med. Dr. rer. nat. Matthias Kroiss
kroiss_m[at]ukw.de
Department of Internal Medicine I, Endocrinology & Diabetology, Universitätsklinikum Würzburg
Wissenschaftliche Mitarbeiter:innen
Isabel Weigand